LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000111 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 4, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
15,000
Total Value
$1,706,300.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Exercise/Conversion | 5,000 | $52.27 | $261,350.00 | 46,514 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 105 | $284.14 | $29,834.44 | 46,409 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 33 | $284.55 | $9,390.25 | 46,376 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 157 | $285.74 | $44,860.50 | 46,219 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 1,032 | $286.80 | $295,974.30 | 45,187 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 1,214 | $287.77 | $349,356.54 | 43,973 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 356 | $288.75 | $102,794.86 | 43,617 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 503 | $289.80 | $145,770.51 | 43,114 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 200 | $290.60 | $58,120.00 | 42,914 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 991 | $291.71 | $289,086.49 | 41,923 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Aug 3, 2026 | Sale | 409 | $292.82 | $119,763.01 | 41,514 | Direct | โ | View Details | |
CLO&Secretary | Employee Stock Option (right to buy) | Derivative | Aug 3, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 29,444 | Direct | โ | View Details |